Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$210M |
| 2 |
Jefferies Financial Group
JEF
|
+$187M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$126M |
| 4 |
Trip.com Group
TCOM
|
+$93.6M |
| 5 |
TAL Education Group
TAL
|
+$85.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$416M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$213M |
| 3 |
Amazon
AMZN
|
+$209M |
| 4 |
Stellantis
STLA
|
+$180M |
| 5 |
TripAdvisor
TRIP
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 36.34% |
| 2 | Communication Services | 17.69% |
| 3 | Healthcare | 14.09% |
| 4 | Technology | 9.35% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Stratasys
SSYS
$679M
| $4.7M | 0.01% |
229,400
| – | – |
|
|
MB
177
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $4.54M | 0.01% |
+165,261
| New | +$4.25M |
|
178
Wipro
WIT
$19.6B
| $3.57M | 0.01% |
1,862,213
+16,160
| +0.9% | +$29.5K |
|
179
HUTCHMED
HCM
$1.93B
| $3.15M | ﹤0.01% |
157,892
+4,189
| +3% | +$62.9K |
|
|
KDNY
180
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.12M | ﹤0.01% |
58,000
| – | – |
|
181
Weibo
WB
$2B
| $3.11M | ﹤0.01% |
59,653
-1,529
| -2% | -$76.1K |
|
182
Rio Tinto
RIO
$158B
| $2.87M | ﹤0.01% |
70,626
| – | – |
|
|
ONC
183
BeOne Medicines Ltd
ONC
$32.8B
| $2.59M | ﹤0.01% |
70,865
+1,581
| +2% | +$57.6K |
|
|
FCT
184
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $2.54M | ﹤0.01% |
183,676
-617,215
| -77% | -$8.54M |
|
|
ATVI
185
DELISTED
Activision Blizzard
ATVI
| $2.21M | ﹤0.01% |
44,300
| – | – |
|
186
Regeneron Pharmaceuticals
REGN
$78.5B
| $2.13M | ﹤0.01% |
5,500
| – | – |
|
187
Acacia Research
ACTG
$428M
| $2.1M | ﹤0.01% |
365,820
| – | – |
|
|
BGB
188
Blackstone Strategic Credit 2027 Term Fund
BGB
$499M
| $2.04M | ﹤0.01% |
+128,690
| New | +$2.03M |
|
189
Nuveen Credit Strategies Income Fund
JQC
$704M
| $2.01M | ﹤0.01% |
+230,900
| New | +$2.04M |
|
|
BZUN
190
Baozun
BZUN
$167M
| $1.58M | ﹤0.01% |
+106,132
| New | +$1.51M |
|
191
CEVA Inc
CEVA
$910M
| $1.52M | ﹤0.01% |
+42,847
| New | +$1.48M |
|
192
SK Telecom
SKM
$12.1B
| $1.47M | ﹤0.01% |
35,360
+618
| +2% | +$23.1K |
|
|
BIOA
193
DELISTED
BioAmber Inc.
BIOA
| $1.34M | ﹤0.01% |
579,540
| – | – |
|
|
FOMX
194
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.09M | ﹤0.01% |
219,400
| – | – |
|
195
NetEase
NTES
$85.3B
| $527K | ﹤0.01% |
9,280
+2,720
| +41% | +$146K |
|
196
Xylem
XYL
$27.3B
| $274K | ﹤0.01% |
+5,457
| New | +$266K |
|
197
Korea Electric Power
KEP
$15.3B
| $269K | ﹤0.01% |
13,000
+9,000
| +225% | +$169K |
|
198
Ecolab
ECL
$78.1B
| $254K | ﹤0.01% |
+2,027
| New | +$248K |
|
|
KITE
199
DELISTED
Kite Pharma, Inc.
KITE
| $201K | ﹤0.01% |
+2,564
| New | +$159K |
|
|
EFR
200
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
| – | – |
-964,976
| Closed | -$14.2M |
|
Similar funds
Baillie Gifford & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Baillie Gifford & Co held 211 positions worth $68.7B, up 13% from $60.8B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Baillie Gifford & Co's Q1 2017 filing shows 13 new, 53 increased, 100 reduced and 11 closed positions. Its largest new stake was Qiagen: 6,818,876 shares worth $209M. The largest sale was First Republic Bank, an estimated $416M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q1 2017 buy was Qiagen: 6,818,876 shares worth $209M.
- Baillie Gifford & Co added most to Jefferies Financial Group in Q1 2017, an estimated $187M increase.
- Baillie Gifford & Co's biggest Q1 2017 reduction was First Republic Bank, cutting an estimated $416M.
- Baillie Gifford & Co fully exited QIAGEN NV in Q1 2017, selling an estimated $213M.
- Baillie Gifford & Co's ten largest holdings make up 50% of its $68.7B portfolio in Q1 2017.
- Baillie Gifford & Co opened 13 new positions and closed 11 in Q1 2017.
- Baillie Gifford & Co's portfolio value rose 13% quarter-over-quarter to $68.7B.
Based on Baillie Gifford & Co's 13F filing for Q1 2017, filed 12 May 2017.